Skip to main content
Figure 5 | BMC Gastroenterology

Figure 5

From: Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma

Figure 5

Cumulative recurrence free survival rate between percutaneous radiofrequency thermal ablation (PRFA) group patients with liver cirrhosis (LC) (n = 127) and surgical resection (SR) group patients with liver cirrhosis (LC) (n = 50). The 1-, 3- and 5-year recurrence free survival rates after PRFA and SR were 86.0%, 35.0% and 14.8%, respectively in the PRFA group with LC and 79.5%, 39.3% and 23.8%, respectively in the SR group with LC. There was no significant differences between these two groups as determined using the log-rank test (P = 0.669).

Back to article page